Clinical Trials on Intracellular Signaling Peptides and Proteins in United States
Total 2998 results
-
BiogenTerminated
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCWithdrawnStudy of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Washington University School of MedicinePaula C. & Rodger O. Riney Blood Cancer ResearchNot yet recruitingMultiple MyelomaUnited States
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthAmgenSuspendedMultiple MyelomaUnited States
-
University of California, San FranciscoCompleted
-
Wake Forest University Health SciencesGlaxoSmithKline; AmgenActive, not recruitingMultiple MyelomaUnited States
-
University of ArkansasActive, not recruitingMultiple MyelomaUnited States
-
Washington University School of MedicineSanofiTerminatedMultiple MyelomaUnited States
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Duke UniversityCompleted
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Yale UniversityCompleted
-
Spectrum Health HospitalsCompletedMultiple MyelomaUnited States
-
Washington University School of MedicineCompleted
-
University of ArkansasCompleted
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
University of RochesterTerminatedMultiple MyelomaUnited States
-
University of ArkansasCompleted
-
University of California, San FranciscoWithdrawn
-
University of ArkansasTerminated
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
University of ArkansasWithdrawnMultiple MyelomaUnited States
-
Cristina GasparettoCelgene CorporationCompletedMultiple MyelomaUnited States
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
AEterna ZentarisCompletedMultiple MyelomaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
University of ArkansasWithdrawnMultiple MyelomaUnited States
-
The University of Texas Health Science Center,...WithdrawnHealthy | Von Willebrand's DisorderUnited States
-
Nationwide Children's HospitalThe Hospital for Sick ChildrenCompleted
-
University of RochesterNational Cancer Institute (NCI)RecruitingMyelomaUnited States
-
University of ArkansasAmgenTerminatedMultiple MyelomaUnited States
-
University of South FloridaMerck Sharp & Dohme LLCTerminatedX-linked Agammaglobulinemia | Specific Antibody Deficiency | Common Variable Immune DeficiencyUnited States
-
NovartisAmgenTerminated
-
University of ArkansasUnknownMultiple MyelomaUnited States
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
Massachusetts General HospitalMultiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
University of UtahCantex PharmaceuticalsTerminatedMultiple MyelomaUnited States
-
ChimerixActive, not recruiting
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Genzyme, a Sanofi CompanyAnorMEDTerminatedMultiple MyelomaUnited States
-
Pennington Biomedical Research CenterFrank L. Greenway; Robbie A. Beyl; Prachi SinghRecruitingDiabetes Mellitus, Type 2 | Overweight and Obesity | Insulin | Glucose | C-Reactive Protein | FructosamineUnited States
-
Eli Lilly and CompanySigilon Therapeutics, Inc.TerminatedHemophilia AUnited Kingdom, United States
-
University of ArkansasJanssen, LPActive, not recruitingMultiple MyelomaUnited States
-
Tulane UniversityGenentech, Inc.Recruiting
-
Mayo ClinicNot yet recruitingMultiple MyelomaUnited States